BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32210117)

  • 21. YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.
    Akiyama Y; Ashizawa T; Komiyama M; Miyata H; Oshita C; Omiya M; Iizuka A; Kume A; Sugino T; Hayashi N; Mitsuya K; Nakasu Y; Yamaguchi K
    Oncol Rep; 2014 Jul; 32(1):159-66. PubMed ID: 24842123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo.
    Huang K; Chen Y; Zhang R; Wu Y; Ma Y; Fang X; Shen S
    Cell Death Dis; 2018 Feb; 9(2):157. PubMed ID: 29410403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Honokiol Induces Autophagic Apoptosis in Neuroblastoma Cells through a P53-Dependent Pathway.
    Lin MC; Lee YW; Tseng YY; Lin YW; Chen JT; Liu SH; Chen RM
    Am J Chin Med; 2019; 47(4):895-912. PubMed ID: 31091975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of cyclin E1 overcomes temozolomide resistance in glioblastoma by Mcl-1 degradation.
    Liang H; Chen Z; Sun L
    Mol Carcinog; 2019 Aug; 58(8):1502-1511. PubMed ID: 31045274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide.
    Alafate W; Wang M; Zuo J; Wu W; Sun L; Liu C; Xie W; Wang J
    Pathol Res Pract; 2019 Nov; 215(11):152617. PubMed ID: 31563286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Honokiol Is a Potential Therapeutic Agent and Has a Synergistic Effect With 5-FU in Human Urothelial Cell Carcinoma Cells.
    Lee MY; Shi CS; Hsu YC; Huang KJ; Chen SH; Zhao PW; Chung HC; Huang YC; Lee YR
    Anticancer Res; 2019 Dec; 39(12):6555-6565. PubMed ID: 31810921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of survivin and p53 modulates honokiol-induced apoptosis in colorectal cancer cells.
    Lai YJ; Lin CI; Wang CL; Chao JI
    J Cell Biochem; 2014 Nov; 115(11):1888-99. PubMed ID: 24905183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of extremely low-frequency electromagnetic field (100 Hz, 100 G) exposure on human glioblastoma U87 cells during Temozolomide administration.
    Ahmadi-Zeidabadi M; Akbarnejad Z; Esmaeeli M; Masoumi-Ardakani Y; Mohammadipoor-Ghasemabad L; Eskandary H
    Electromagn Biol Med; 2019; 38(3):198-209. PubMed ID: 31179753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Honokiol induces caspase-independent paraptosis via reactive oxygen species production that is accompanied by apoptosis in leukemia cells.
    Wang Y; Zhu X; Yang Z; Zhao X
    Biochem Biophys Res Commun; 2013 Jan; 430(3):876-82. PubMed ID: 23262230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.
    Banelli B; Carra E; Barbieri F; Würth R; Parodi F; Pattarozzi A; Carosio R; Forlani A; Allemanni G; Marubbi D; Florio T; Daga A; Romani M
    Cell Cycle; 2015; 14(21):3418-29. PubMed ID: 26566863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Honokiol induces autophagy and apoptosis of osteosarcoma through PI3K/Akt/mTOR signaling pathway.
    Li Z; Dong H; Li M; Wu Y; Liu Y; Zhao Y; Chen X; Ma M
    Mol Med Rep; 2018 Feb; 17(2):2719-2723. PubMed ID: 29207060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway.
    Xu P; Zhang G; Hou S; Sha LG
    Biomed Pharmacother; 2018 Oct; 106():1419-1427. PubMed ID: 30119215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells.
    Yang SE; Hsieh MT; Tsai TH; Hsu SL
    Biochem Pharmacol; 2002 May; 63(9):1641-51. PubMed ID: 12007567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Honokiol-induced apoptosis of human non-Hodgkin lymphoma Raji cells and its possible mechanism].
    Chen W; Lin GW; Zhang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1918-21. PubMed ID: 22126780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line.
    Ashizawa T; Akiyama Y; Miyata H; Iizuka A; Komiyama M; Kume A; Omiya M; Sugino T; Asai A; Hayashi N; Mitsuya K; Nakasu Y; Yamaguchi K
    Int J Oncol; 2014 Jul; 45(1):411-8. PubMed ID: 24820265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells.
    Chilampalli C; Guillermo R; Kaushik RS; Young A; Chandrasekher G; Fahmy H; Dwivedi C
    Exp Biol Med (Maywood); 2011 Nov; 236(11):1351-9. PubMed ID: 21908486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Honokiol up-regulates prostacyclin synthease protein expression and inhibits endothelial cell apoptosis.
    Zhang X; Chen S; Wang Y
    Eur J Pharmacol; 2007 Jan; 554(1):1-7. PubMed ID: 17109844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma.
    Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W
    Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
    Park EJ; Min HY; Chung HJ; Hong JY; Kang YJ; Hung TM; Youn UJ; Kim YS; Bae K; Kang SS; Lee SK
    Cancer Lett; 2009 May; 277(2):133-40. PubMed ID: 19135778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.